Inside Mark Kvamme’s Second Bet: Ohio Growth Push
Veteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
Glide paths in target date funds describe how asset allocations shift automatically as retirement nears, balancing growth and risk over time. This intro explains the idea and why it matters for planning.
25,488 articlesVeteran investor Mark Kvamme is rolling out a Temasek style OHIO Fund, a $500 million vehicle aimed at accelerating g...
If you want growth exposure without buying dozens of stocks, the Vanguard Growth ETF (VUG) could be a fit. This guide...
A major moment for cannabis investing has arrived. A U.S. cannabis company began trading on a flagship exchange, sign...
Intel prepares for a pivotal investor update, and investors want to know whether buying now makes sense. This guide b...
The market is navigating a phase many haven’t seen in a generation. Mega-cap tech dominates, valuations look stretche...
A 70-year-old aims to generate $69,600 a year from a $1.1 million portfolio, testing whether higher-yield income stra...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
Many savers focus on how much to contribute and how to invest. But a hidden 401(k) option can dramatically improve yo...
Two popular U.S. dividend ETFs take different paths to income. This guide breaks down how SCHD and FDVV approach divi...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
Choosing the right pharmaceutical ETF can shape your portfolio’s risk and income. This guide pits IHE against PJP, br...
When a sudden death upends a family, money worries often follow. This article uses Nolan Wells’ Independent Autopsy a...